Evidence map›Paper›PMID 29726971›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2018

The Role of Endocrine and Dioxin-Like Activity of Extracts of Petroleum Substances in Developmental Toxicity as Detected in a Panel of CALUX Reporter Gene Assays.

Lenny Kamelia, Jochem Louisse, Laura de Haan, Anna Maslowska-Gornicz, Hans B Ketelslegers, Abraham Brouwer, Ivonne M C M Rietjens, Peter J Boogaard

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Use of Computational Models to Investigate Human Targets of Small Ubiquitous Molecules.Chembiochem : a European journal of chemical biology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Lenny KameliaDivision of Toxicology, Wageningen University and Research, 6708 WE Wageningen, The Netherlands.
Jochem LouisseDivision of Toxicology, Wageningen University and Research, 6708 WE Wageningen, The Netherlands.
Laura de HaanDivision of Toxicology, Wageningen University and Research, 6708 WE Wageningen, The Netherlands.
Anna Maslowska-GorniczDivision of Toxicology, Wageningen University and Research, 6708 WE Wageningen, The Netherlands.
Hans B KetelslegersEuropean Petroleum Refiners Association, Concawe Division, 1160 Brussels, Belgium.
Abraham BrouwerBioDetection Systems, 1098XH Amsterdam, The Netherlands.
Ivonne M C M RietjensDivision of Toxicology, Wageningen University and Research, 6708 WE Wageningen, The Netherlands.
Peter J BoogaardDivision of Toxicology, Wageningen University and Research, 6708 WE Wageningen, The Netherlands.
Wageningen University & Research · NLBioDetection Systems (Netherlands) · NLConcawe · BEShell (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent evidence suggests that the interaction of polycyclic aromatic hydrocarbons (PAHs), present in some petroleum substances (PS), with particular nuclear-hormone-receptors and/or the dioxin (aryl hydrocarbon receptor [AhR]) receptor, may play a role in the prenatal developmental toxicity (PDT) induced by these substances. To address this hypothesis, we evaluated the possible endocrine and dioxin-like activity of the dimethylsulfoxide (DMSO)-extracts of 9 PS, varying in PAH content, and 2 gas-to-liquid (GTL) products, containing no PAHs but having similar other properties as PS, using a series of Chemical Activated LUciferase gene eXpression (CALUX) assays. The results show that the extracts of PS tested in this study possess various endocrine and dioxin-like activities and these in vitro potencies are associated with the quantity and type of PAHs they contain. All tested DMSO-extracts of PS show a strong AhR agonist activity and rather weak antiprogesterone, antiandrogen, and estrogenic activities. In the assays that evaluate thyroid-related and antiestrogen activity, only minor effects of specific extracts, particularly those with a substantial amount of 4-5 ring PAHs, ie, sample No. 34, 98, and 99, were observed. None of the GTL extracts interacted with the selected receptors. Of all assays, the AhR agonist activity correlates best (R2 = 0.80) with the in vitro PDT of the substances as quantified previously in the embryonic stem cell test, suggesting an important role of the AhR in mediating this effect. Hierarchic clustering of the combined CALUX data clustered the compounds in line with their chemical characteristics, suggesting a PS class-specific effects signature in the various CALUX assays, depending on the PAH profile. To conclude, our findings indicate a high potential for endocrine and dioxin-like activity of some PS extracts which correlates with their in vitro PDT and is driven by the PAHs present in these substances.

Indexed as

Androgen Receptor AntagonistsAnimalsCell LineCell Line, TumorDimethyl SulfoxideDioxinsEnvironmental PollutantsEstrogen Receptor alphaGenes, ReporterHumansMutagenicity TestsPetroleumPolycyclic Aromatic HydrocarbonsRatsReceptors, AndrogenReceptors, Aryl HydrocarbonAndrogen Receptor AntagonistsDimethyl SulfoxideDioxinsEnvironmental PollutantsEstrogen Receptor alphaPetroleumPolycyclic Aromatic HydrocarbonsReceptors, AndrogenReceptors, Aryl HydrocarbonReceptors, ProgesteroneThyroid Hormone Receptors beta

Identifiers

PMID29726971
PMCPMC6061685
OpenAlexW2801988108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.